PolyPeptide Group AG (SWX:PPGN)
Switzerland · Delayed Price · Currency is CHF 27.30
-0.65 (-2.33%)
At close: Jan 30, 2026
PolyPeptide Group AG Market Cap
PolyPeptide Group AG has a market cap or net worth of 900.67 million as of January 30, 2026. Its market cap has increased by 6.87% in one year.
Market Cap
900.67M
Enterprise Value
933.00M
Revenue
344.49M
Ranking
n/a
PE Ratio
n/a
Stock Price
27.30
Market Cap Chart
Since April 29, 2021, PolyPeptide Group AG's market cap has decreased from 2.59B to 900.67M, a decrease of -65.23%. That is a compound annual growth rate of -19.91%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 30, 2026 | 900.67M | 4.60% |
| Dec 30, 2025 | 861.08M | -8.08% |
| Dec 30, 2024 | 936.73M | 62.30% |
| Dec 29, 2023 | 577.18M | -30.79% |
| Dec 30, 2022 | 833.98M | -81.57% |
| Dec 30, 2021 | 4.53B | 74.70% |
| Apr 29, 2021 | 2.59B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Roche Holding AG | 299.12B |
| Novartis AG | 223.58B |
| Lonza Group AG | 39.22B |
| Galderma Group AG | 35.14B |
| Tecan Group AG | 1.79B |
| SKAN Group AG | 1.34B |
| Aevis Victoria | 1.17B |
| Medartis Holding AG | 1.16B |